Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Añadir filtros








Intervalo de año
1.
Einstein (Säo Paulo) ; 20: eAO6450, 2022. tab, graf
Artículo en Inglés | LILACS | ID: biblio-1364794

RESUMEN

ABSTRACT Objective To understand the feasibility of FGFR3 tests in the Brazilian public health context, and to sample the mutational burden of this receptor in high-grade muscle invasive bladder cancer. Methods A total of 31 patients with high-grade muscle-invasive bladder cancer were included in the present study. Either transurethral resection of bladder tumor or radical cystectomy specimens were analyzed. Formalin-fixed paraffin-embedded tissue blocks were sectioned, hematoxylin and eosin stained, and histologic sections were reviewed. Total RNA was extracted using the RNeasy DSP formalin-fixed paraffin-embedded kit. Qualitative results were displayed in Rotor-Gene AssayManager software. Results Six patients were excluded. From the samples analyzed, four (16.7%) were considered inadequate and could not have their RNA extracted. Two patients presented FGFR3 mutations, accounting for 9.5% of material available for adequate analysis. The two mutations detected included a Y373C mutation in a male patient and a S249C mutation in a female patient. Conclusion FGFR3 mutations could be analyzed in 84% of our cohort and occurred in 9.5% of patients with high-grade muscle invasive bladder cancer in this Brazilian population. FGFR3 gene mutations are targets for therapeutic drugs in muscle-invasive bladder cancer. For this reason, know the frequency of these mutations can have a significant impact on public health policies and costs provisioning.


Asunto(s)
Neoplasias de la Vejiga Urinaria/genética , Carcinoma de Células Transicionales/genética , Carcinoma de Células Transicionales/metabolismo , Carcinoma de Células Transicionales/patología , Receptor Tipo 3 de Factor de Crecimiento de Fibroblastos/genética , Receptor Tipo 3 de Factor de Crecimiento de Fibroblastos/metabolismo , Brasil , ARN , Prevalencia , Eosina Amarillenta-(YS) , Hematoxilina , Músculos/metabolismo , Músculos/patología , Mutación
2.
Arq. neuropsiquiatr ; 57(4): 959-64, dez. 1999. ilus, graf
Artículo en Portugués | LILACS | ID: lil-249295

RESUMEN

A determinação do conteúdo de DNA nuclear (fração de fase S e ploidia de DNA) foi realizada por meio de análise de imagem em 66 astrocitomas, a partir de material fixado em formalinas e seccionado em cortes de 5 micrômetros corados pela técnica de Feulgen. Nossos resultados mostraram forte relação entre a idade do paciente, grau histológico e sobrevida, com a ploidia de DNA e o percentual de células em fase de síntese. A análise da atividade proliferativa de astrocitomas intracranianos é a nosso ver muito útil no entendimento do comportamento biológico, do prognóstico e para o planejamento terapêutico dessas lesões.


Asunto(s)
Adulto , Niño , Preescolar , Persona de Mediana Edad , Humanos , Femenino , Adolescente , Astrocitoma/genética , Neoplasias Encefálicas/genética , ADN de Neoplasias/genética , Ploidias , Astrocitoma/patología , Neoplasias Encefálicas/patología , Brasil , Estadificación de Neoplasias
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA